The epidemiology of imported and locally-acquired dengue in Australia, 2012-2022.
arbovirus
imported infection
infectious disease
notifiable disease
surveillance
travel
Journal
Journal of travel medicine
ISSN: 1708-8305
Titre abrégé: J Travel Med
Pays: England
ID NLM: 9434456
Informations de publication
Date de publication:
18 Jan 2024
18 Jan 2024
Historique:
received:
12
12
2023
revised:
15
01
2024
medline:
20
1
2024
pubmed:
20
1
2024
entrez:
20
1
2024
Statut:
aheadofprint
Résumé
Dengue is the most important arboviral disease globally, and poses ongoing challenges for control including in non-endemic countries with competent mosquito vectors at risk of local transmission through imported cases. We examined recent epidemiological trends in imported and locally-acquired dengue in Australia, where the Wolbachia mosquito population replacement method was implemented throughout dengue-prone areas of northern Queensland between 2011-2019. We analysed dengue cases reported to the Australian National Notifiable Disease Surveillance System (NNDSS) between January 2012 and December 2022, and Australian traveller movement data. Between 2012 and 2022, 13 343 dengue cases were reported in Australia (median 1466 annual cases); 12 568 cases (94.2%) were imported, 584 (4.4%) were locally acquired and 191 (1.4%) had no origin recorded. Locally-acquired cases decreased from a peak in 2013 (n = 236) to zero in 2021-2022. Annual incidence of imported dengue ranged from 8·29/100000 (n = 917 cases) to 22·10/100000 (n = 2203) annual traveller movements between 2012 and 2019, decreased in 2020 (6·74/100000 traveller movements; n = 191) and 2021 (3·32/100000 traveller movements; n = 10) during COVID-19-related border closures, then rose to 34·79/100000 traveller movements (n = 504) in 2022. Imported cases were primarily acquired in Southeast Asia (n = 9323; 74%), Southern and Central Asia (n = 1555; 12%) and Oceania (n = 1341; 11%). Indonesia (n = 5778; 46%) and Thailand (n = 1483; 12%) were top acquisition countries. DENV-2 (n = 2147; 42%) and DENV-1 (n = 1526; 30%) were predominant serotypes. Our analysis highlights Australia's successful control of locally-acquired dengue with Wolbachia. Imported dengue trends reflect both Australian travel destinations and patterns and local epidemiology in endemic countries. AS is supported by a National Health and Medical Research (NHMRC) Postgraduate Scholarship (grant number 2002792), SLM by NHMRC Investigator Grants (grant number 2017229), KL by a NHMRC Senior Research Fellowship (grant number 1155005), and KLA by the Welcome Trust (grant number 224459/Z/21/Z).
Sections du résumé
BACKGROUND
BACKGROUND
Dengue is the most important arboviral disease globally, and poses ongoing challenges for control including in non-endemic countries with competent mosquito vectors at risk of local transmission through imported cases. We examined recent epidemiological trends in imported and locally-acquired dengue in Australia, where the Wolbachia mosquito population replacement method was implemented throughout dengue-prone areas of northern Queensland between 2011-2019.
METHODS
METHODS
We analysed dengue cases reported to the Australian National Notifiable Disease Surveillance System (NNDSS) between January 2012 and December 2022, and Australian traveller movement data.
RESULTS
RESULTS
Between 2012 and 2022, 13 343 dengue cases were reported in Australia (median 1466 annual cases); 12 568 cases (94.2%) were imported, 584 (4.4%) were locally acquired and 191 (1.4%) had no origin recorded. Locally-acquired cases decreased from a peak in 2013 (n = 236) to zero in 2021-2022. Annual incidence of imported dengue ranged from 8·29/100000 (n = 917 cases) to 22·10/100000 (n = 2203) annual traveller movements between 2012 and 2019, decreased in 2020 (6·74/100000 traveller movements; n = 191) and 2021 (3·32/100000 traveller movements; n = 10) during COVID-19-related border closures, then rose to 34·79/100000 traveller movements (n = 504) in 2022. Imported cases were primarily acquired in Southeast Asia (n = 9323; 74%), Southern and Central Asia (n = 1555; 12%) and Oceania (n = 1341; 11%). Indonesia (n = 5778; 46%) and Thailand (n = 1483; 12%) were top acquisition countries. DENV-2 (n = 2147; 42%) and DENV-1 (n = 1526; 30%) were predominant serotypes.
CONCLUSION
CONCLUSIONS
Our analysis highlights Australia's successful control of locally-acquired dengue with Wolbachia. Imported dengue trends reflect both Australian travel destinations and patterns and local epidemiology in endemic countries.
FUNDING
BACKGROUND
AS is supported by a National Health and Medical Research (NHMRC) Postgraduate Scholarship (grant number 2002792), SLM by NHMRC Investigator Grants (grant number 2017229), KL by a NHMRC Senior Research Fellowship (grant number 1155005), and KLA by the Welcome Trust (grant number 224459/Z/21/Z).
Identifiants
pubmed: 38243558
pii: 7577676
doi: 10.1093/jtm/taae014
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : National Health and Medical Research
ID : 2002792
Organisme : NHMRC Investigator Grants
ID : 2017229
Organisme : NHMRC Senior Research Fellowship
ID : 1155005
Organisme : Welcome Trust
ID : 224459/Z/21/Z
Informations de copyright
© The Author(s) 2024. Published by Oxford University Press on behalf of International Society of Travel Medicine.